. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. Am J Physiol Heart Circ Physiol 285: H2316-H2326, 2003; 10.1152/ajpheart. 00229.2003.-Pentose phosphate pathway (PPP) inhibitors, 6-aminonicotinamide (6-AN) and epiandrosterone (Epi), were employed to examine whether changes in NADP(H) redox regulates contractile force in endothelium-removed bovine coronary arteries (BCAs). 6-AN (0.01-5 mM) or Epi (1-500 M) elicited dose-dependent relaxation in BCAs contracted with 30 mM KCl, 0.1 M U-44619, and endothelin-1 but not with phorbol 12,13-dibutyrate, a protein kinase C activator that causes Ca 2ϩ -independent contraction. Relaxation to PPP inhibition was associated with oxidation of NADPH and glutathione (GSH). Relaxation to 6-AN was not mediated by H 2O2, because it was not altered by hypoxia or the peroxide scavenger ebselen (100 M). The thiol reductant DTT (3 mM) attenuated the relaxation to 6-AN and Epi by 30-40%. Inhibition of glycolysis or mitochondrial electron transport did not elicit relaxation in BCAs contracted with 30 mM KCl, suggesting these pathways may not be involved in relaxation elicited by PPP inhibition. High doses of K ϩ channel blockers [e.g., TEA (10 mM) and 4-aminopyridine (10 mM)] only partially inhibited the relaxation to 6-AN. On the basis of changes in the fura-2 fluorescence ratio, 6-AN and Epi appeared to markedly reduce intracellular Ca 2ϩ . Thus PPP inhibition oxidizes NADPH and GSH and appears to activate a novel coordination of redox-controlled relaxing mechanisms in BCAs mediated primarily through decreasing intracellular Ca 2ϩ .
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calcium; redox signaling; vasodilator mechanisms SOME of the primary smooth muscle cellular redox systems appear to have major roles in controlling signaling systems that regulate vasomotor tone (22, (25) (26) (27) . Our previous studies examining cytosolic NAD(H) redox modulation through the lactate dehydrogenase reaction have provided evidence that this system controls the generation of superoxide by an NADH oxidase present in bovine pulmonary (BPA) and coronary arterial (BCA) smooth muscle. Subsequently, H 2 O 2 -derived from this oxidase mediates relaxation, whereas inhibition of Cu,Zn-SOD causes an attenuation of relaxation by nitric oxide (NO) and other stimuli of soluble guanylate cyclase (sGC) through increasing superoxide levels (6, 14, 15, 26) . Recent studies have suggested that changes in reactive O 2 species, NADH, and thiol redox regulate the opening of voltage-gated K ϩ (K v ) and Ca 2ϩ -activated K ϩ (K Ca ) channels, which hyperpolarize vascular smooth muscle (VSM) (11, 17, 18, 22, 25) . Our studies on the actions of the thiol oxidant diamide indicate that this agent causes BCA relaxation through closing of L-type Ca 2ϩ channels controlled by GSH redox, a response not altered by K ϩ channel inhibition (9) . The existence of multiple signaling mechanisms potentially regulated through thiol redox, and the interactive influence of thiol redox and NADP(H) redox through systems including GSH reductase and thioredoxin reductase, suggests that additional vascular regulatory mechanisms could also be controlled through changes in the redox status of components of these systems (26) .
It is now well established that NADPH derived from the pentose phosphate pathway (PPP) is a key system involved in maintaining the function of several important redox and antioxidant defense mechanisms, through processes such as reducing oxidized GSH (GSSG), and other thiol and heme-linked systems. Recent studies have begun to detect potentially important roles for the PPP and NADP(H) redox in the control of signaling processes. For example, PPP-derived NADPH is an essential cofactor for NO production by NO synthase (8, 12) and for controlling NO-induced relaxation in bovine arteries through a NADPH-dependent methemoprotein reductase, which maintains the heme of sGC in its NO-binding ferrous form (7) . In these studies on the actions of NO and heme oxidants on sGC, the PPP inhibitors 6-aminonicotinamide (6-AN) and epiandrosterone (Epi) were employed to inhibit the generation of NADPH. An early hypothesis on the mechanism of hypoxic vasoconstriction proposed a role for the loss of a relaxing mechanism mediated through the lowering of oxidant generation and NAD(P) ϩ and GSSG levels (22) , which potentially open VSM K ϩ channels through processes such as regulating the redox states of thiols (22, 25) . PPP inhibitors have recently been reported to contribute to the relaxation in the rat pulmonary artery and aorta through hyperpolarizing VSM by opening of K v channels (5) and reduction of myocardial contractility by inhibition of L-type Ca 2ϩ channels in cardiac myocytes (8) . Thus PPP-derived NADPH could be important in regulating the signaling mechanisms that control vasomotor function.
The present study was developed based on the observation that the PPP inhibitors 6-AN and Epi caused relaxation of BCAs. Because inhibition of the PPP could potentially cause oxidation of the cytosolic NADP(H) and GSH redox systems and increase H 2 O 2 levels in VSM due to the loss of metabolic control mechanisms, components of each of these systems could be involved in producing relaxation of coronary arteries. On the basis of previous observations, roles for modulating the production of cGMP by sGC, K ϩ channel opening-induced hyperpolarization, and processes that modulate intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) needed to be considered in the evaluation of the mechanisms through which PPP inhibition could cause relaxation of VSM. Thus this study focuses on providing evidence that PPP inhibition increases NADP ϩ -to-NADPH and GSSG-to-GSH ratios associated with activating vascular relaxation through processes that suppress [Ca 2ϩ ] i .
MATERIALS AND METHODS
Many of the reagents used in the present study were obtained from sources previously described (6, 7, 9, 14, 15) . Most vasoactive and mechanistic probes were purchased from Sigma Chemical (St. Louis, MO) except for LY-83583 and U-46619, which were from Cayman Chemical (Ann Arbor, MI).
Measurement of changes of force generation in BCAs. Isolated, endothelium-removed left anterior descending coronary arterial rings were prepared from slaughterhouse-derived bovine hearts and studied for changes in isometric force, as previously described (6, 7, 9, 14, 15) . The rings were incubated in individually thermostated (37°C) 10-ml baths (Metro Scientific) for 2 h at an optimal passive tension of 5 g in Krebs bicarbonate buffer (pH 7.4) containing the following (in mM): 118 NaCl, 4.7 KCl, 1.5 CaCl2, 25 NaHCO3, 1.1 MgSO4, 1.2 KH2PO4, and 5.6 glucose, gassed with 21% O2-5% CO2-balance N2. After a 2-h equilibration and a brief depolarization with 123 mM KCl, BCAs were reequilibrated in Krebs buffer for 30 min before the experiments described in RESULTS were conducted. In studies examining the actions of mechanistic inhibitors on the response to 6-AN and Epi, probes were usually added at least 15 min before exposure to increasing cumulative concentrations of 6-AN, Epi, or other relaxing agents. None of the probes or treatments, except those mentioned in RESULTS, had a statistically significant effect on force generation.
Measurement of NADPH and NADP ϩ in BCAs. The levels of NAD(P)H in BCAs were determined by HPLC using adaptations of previously published methods (5, 7) . Briefly, BCAs were pretreated with and without 6-AN or Epi in a manner similar to the studies on vascular force and immediately frozen in liquid nitrogen. The frozen tissues were crushed and homogenized in an extraction medium consisting of 0.02 N NaOH containing 0.5 mM cysteine at 0°C. The extracts were then heated at 60°C for 10 min and neutralized with 2 ml of 0.25 M glycylglycine buffer (pH 7.6). Acidic extracts were prepared by homogenizing the tissues in hot 0.1 N HCl, followed by neutralization. NAD(P)H was eluted on a reverse-phase HPLC column (4.6 ϫ 250 mm, Bondapak C 18, Shiseido) at room temperature using a HP 1100 Series (Agilent Technologies) and buffer system consisting of 100 mM potassium phosphate (pH 6.0; buffer A) and 100 mM potassium phosphate (pH 6.0) containing 5% methanol (buffer B). The column was eluted with 100% buffer A from 0 to 8.5 min, 80% buffer A plus 20% buffer B from 8.5 to 14.5 min, and 100% buffer B from 14.5 to 40 min. The flow rate was 1.0 ml/min, and the ultraviolet absorbance was monitored at 260 nm.
Measurement of glutathione levels in BCAs. Frozen BCAs pretreated with or without 6-AN or Epi were crushed in liquid nitrogen, homogenized in 50 mM potassium phosphate buffer (pH 6-7) and 1 mM EDTA, and then centrifuged at 10,000 g for 15 min at 4°C. The supernatant was used for measurement of GSH and GSSG after the samples were deproteinated. The GSH and GSSG levels were determined by employing a kit purchased from Cayman Chemical.
Measurement of superoxide and hydrogen peroxide levels in BCAs. Employing previously described methods (14, 15) , we prepared BCAs as described for force measurement, but the rings pretreated with or without drugs in the tissue bath were placed in plastic scintillation minivials containing 5 M lucigenin for the detection of superoxide and 10 M luminol plus 1 M horseradish peroxidase for the detection of H 2O2 and other additions in a final volume of 1 ml of air-equilibrated Krebs solution buffered with 10 mM HEPES-NaOH (pH 7.4). Chemiluminescence was measured in a liquid scintillation counter (LS6000IC, Beckman Instruments) at ϳ37°C, and data are reported as counts per minute per gram of BCA after background subtraction. The inhibition of chemiluminescence by the addition of 1 M catalase was used for measurement of H2O2 released from BCAs, which occurs when GSH peroxidase activity is inhibited (15) .
Estimation of smooth muscle [Ca 2ϩ ]i by fura-2 fluorescence ratios. In separate experiments, the smooth muscle of isolated coronary arteries was loaded with fura-2 (2 M fura-2 AM, 30 min at 25°C). Changes in background-corrected fura-2 fluorescence ratios (F340/F380; the ratio of 510-nm emission intensity resulting from excitation at 340 nm divided by the emission intensity from excitation at 380 nm) and estimates of smooth muscle [Ca 2ϩ ]i were measured by the ratiometric fluorescence method using the Ionoptix Microfluorimeter System (Ionoptix) as previously described in detail (23, 24) . VSM was depolarized with 30 mM KCl, and changes in smooth muscle [Ca 2ϩ ]i to 6-AN (0.010-1 mM), Epi (0.001-0.100 mM), and nifedipine (10 M) were obtained. In other experiments, the time course of changes in smooth muscle [Ca 2ϩ ]i to 5-hydroxytryptamine (5-HT; 10 M) were assessed in the absence and presence of 1 mM 6-AN or 100 M Epi. Decreases in F340/F380 were normalized to the maximal nifedipine-induced responses, whereas 5-HT-induced increases in F340/F380 were normalized to the maximal response to 5-HT in the absence of 6-AN and Epi.
Statistical analysis. ANOVA statistical analysis employing a post hoc Fisher's protected t-test was used for all studies on vascular contractility. All chemiluminescence and fura-2 data were analyzed by Student's t-tests employing a Bonferroni correction for multiple comparisons. The acceptable level of significance was P Ͻ 0.05. The number of experimental determinations (n) in all cases is equal to the animals from which an arterial ring was employed for a treatment or a control group in all studies. Values are means Ϯ SE.
RESULTS

Effects of 6-AN and Epi on NADP
ϩ and NADPH levels in BCAs. Measurements of NADP(H) in BCAs by HPLC indicated that 5 mM 6-AN and 0.5 mM Epi lower NADPH levels (Fig. 1A) , associated with increases (6-AN: 5.45 Ϯ 0.59 nmol/g wet wt and EPI: 6.33 Ϯ 0.77 nmol/g wet wt vs. control: 1.47 Ϯ 0.48 nmol/g wet wt) in NADP ϩ (Fig. 1B) . These inhibitors attenuated NADPH synthesis in a dose-dependent manner, because lower doses of 6-AN (1 mM, n ϭ 9) and Epi (100 M, n ϭ 8) also decreased NADPH levels (6-AN: 1.95 Ϯ 0.37 nmol/g wet wt and Epi: 2.31 Ϯ 0.34 nmol/g wet wt vs. control: 3.07 Ϯ 0.62 nmol/g wet wt).
6-AN and Epi inhibit BCA contraction to K ϩ and U-46619. Endothelium-denuded BCA rings precontracted to ϳ70% of maximal force by depolarizationand receptor-dependent mechanisms with KCl (30 mM) and the thromboxane A 2 analog U-46619 (100 nM) or endothelin-1 (100 nM), respectively, relaxed in a dose-dependent manner when treated with 6-AN or Epi ( Fig. 1, C and D) . The PPP inhibitors 6-AN and Epi elicited relaxation of BCAs ( Fig. 1, C and D ). In contrast, the BCA precontracted with a PKC activator, phorbol 12,13-dibutyrate (PDBu; 10 M), through a mechanism that is essentially Ca 2ϩ independent (9), did not relax to 6-AN or Epi (Fig. 1, C and D) . Interestingly, inhibition of either glycolysis with 2-deoxyglucose or mitochondrial electron transport by cyanide or antimycin did not cause relaxation of BCAs precontracted with 30 mM KCl (Fig. 1E) .
Effect of 6-AN and Epi on GSH and GSSG levels in BCAs.
The effect of PPP inhibition on GSH and GSSG levels were measured in BCAs in the absence and presence of 6-AN and Epi. Both 6-AN (5 mM) and Epi (0.5 mM) decreased GSH (control: 270 Ϯ 17 g/g, 6-AN: 193 Ϯ 15 g/g, Epi: 200 Ϯ 26 g/g) and increased GSSG (control: 26 Ϯ 7 g/g, 6-AN: 79 Ϯ 17 g/g; Epi: 40 Ϯ 6 g/g) levels in BCAs (Fig. 2, A and B) . These values were converted into molar amounts to enable the calculation of redox ratios (GSH: control 878.6 Ϯ 55.3 nM/g, 6-AN 628.1 Ϯ 48.8 nM/g, and Epi 650.8 Ϯ 84.6 nM/g; GSSG: control 42.4 Ϯ 11.4 nM/g, 6-AN 128.9 Ϯ 27.8 nM/g, and Epi 65.3 Ϯ 9.7 nM/g). GSH-to-GSSG ratios were decreased from 20.7 (control) to 4.9 and 9.9 in the presence of 6-AN and Epi, respectively, indicating that marked changes in GSH redox were occurring in the presence of these PPP inhibitors.
Effect of thiol reduction with DTT on relaxation elicited by PPP inhibition. Because inhibition of the PPP decreased GSH and elevated GSSG levels in BCAs, the effects of the thiol reductant DTT (3 mM), which reduces GSSG or S-thiolated proteins, on relaxation to 6-AN and Epi were examined. BCA rings contracted with KCl (30 mM; Fig. 2 , C and D) or U-46619 (100 nM; data not shown) that were treated with DTT (30 min) Fig. 1 . Summary data showing the effects of pentose phosphate pathway (PPP) inhibitors on oxidizing NAD(P)H in bovine coronary arteries (BCAs) by decreasing NADPH levels (A) and increasing NADP levels (B) and the relaxation observed with increasing cumulative concentrations of 6-aminonicotinamide (6-AN; n ϭ 50-58; C) and epiandersterone (Epi; n ϭ 36-40; D) in the presence of force generated by various contractile agents. E: effects of 1 M-10 mM 2-deoxyglucose (n ϭ 12), 1 M-10 mM cyanide (n ϭ 12), and 1 M-1 mM antimycin (n ϭ 6) in BCAs precontracted with 30 mM KCl. In A and B, control ϭ 30 mM KCl (n ϭ 18), and 5 mM 6-AN (n ϭ 11) and 0.05 mM Epi (n ϭ 9) were used. The contractile data shown in C and D were analyzed by repeated-measures ANOVA and Student's t-test. In the presence of phorbol 12,13-dibutyrate (PDBu), ANOVA test was not statistically significant. * Significant (P Ͻ 0.05) differences compared with 30 mM K ϩ contraction. ET-1, endothelin-1.
showed a significantly inhibited relaxation to 6-AN ( Fig. 2C) and EPI ( Fig. 2D ) compared with responses to PPP inhibition in the absence of DTT. Under these conditions, DTT treatment did not change the force generated by either KCl or U-46619, and it did not significantly effect relaxation to isoproterenol (Fig. 2E ). 3, A and B) . To further probe for an absence of a role for these O 2 species, the actions of PPP inhibitors were investigated under severely hypoxic conditions (95% N 2 -5% CO 2 ) and in the presence of the H 2 O 2 scavenger ebselen. BCAs were relaxed by 100% and 60% by 6-AN (5 mM) and Epi (0.5 mM) under hypoxia (n ϭ 5), and ebselen (n ϭ 11; Fig. 3C (Fig. 4A) , DDA (Fig. 4B) , and CPA did not significantly inhibit the relaxation to 6-AN. In BCAs precontracted with 100 nM U-46619, the relaxation induced by 6-AN (79 Ϯ 6% at 1 mM, n ϭ 5) or Epi (75 Ϯ 6% at 100 M, n ϭ 5) was not significantly altered by CPA (6-AN ϩ CPA: 76 Ϯ 9% relaxation and Epi ϩ CPA: 69 Ϯ 9% relaxation).
Effect of 6-AN and
Effect of K ϩ channel antagonists on relaxation elicited by PPP inhibition. To further examine whether the opening of K ϩ channels by PPP inhibition participates in the observed relaxation, the arteries were pretreated with different K ϩ channel blockers before they were exposed to PPP inhibitors. Pretreatment of BCAs with a nonspecific K ϩ channel blocker, tetraethylammonium chloride (TEA; 10 mM), did not significantly increase force generation by U-46619; however, it caused a small, statistically significant reduction of relaxation to 6-AN (Fig. 5A) . Opening of ATP-sensitive K ϩ (K ATP ) channels did not mediate relaxation, because glibenclamide (10 M, n ϭ 12), a K ATP channel blocker (16), did not effect the relaxation to 6-AN (Fig.  5B) . Roles for small-and large-conductance K Ca channels were probed by blockade with apamin (Apa) and iberiotoxin (IbTX), respectively (16) . Pretreatment of BCAs with either IbTX (23 nM) or Apa (100 nM) caused small decreases in the relaxation to 6-AN, suggesting that relaxation appears to be influenced by the function of both small-and large-conductance K Ca channels (Fig. 5, C and D) . A high dose of the K v channel blocker 4-aminopyridine (4-AP; 10 mM) was used to examine whether the opening of this type of channel contributes to the relaxation elicited by 6-AN. Pretreatment with 4-AP did not significantly alter the contraction to U-46619, whereas it caused a partial inhibition (P Ͻ 0.05) of BCA relaxation to 6-AN (Fig. 5D) . The combi- nation of both 4-AP and IbTX further reduced the relaxation of BCAs to 6-AN (Fig. 5D) , consistent with BCA relaxation being modulated by the function of both K v and K Ca channels. Similar experiments were done using Epi, and we found that inhibition of PPP by Epi also partially caused relaxation of BCAs by regulating the function of K ϩ channels.
Effect of 6-AN and Epi on force generation by 5-HT, U-46619, and KCl in Ca
2ϩ -free buffer and the subsequent contraction to Ca 2ϩ addition. In this series of experiments, vessels were first contracted with 30 mM KCl in normal Krebs solution, followed by washout, and subsequent contractile responses were studied in Ca 2ϩ -free Krebs solution containing 0.1 mM EGTA, as previously described (9). The contractile effects of 100 nM U-46619, 10 M 5-HT, and 30 mM KCl were examined in the absence or presence of a 10-min pretreatment with 6-AN and Epi to detect contractile responses originating from the initial release of intracellular Ca 2ϩ . This was followed ϳ10 min later by the addition of 1.5 mM Ca Ϫ ; n ϭ 8; A) and hydrogen peroxide (H2O2; n ϭ 7; B) production in endothelium-denuded BCAs. Relaxation to 6-AN was not altered by increasing the peroxide consumption with ebselen (n ϭ 11; C). quently sustained tonic contraction was elicited by the addition of 1.5 mM Ca 2ϩ . In the presence of 6-AN and Epi, the initial transient contraction was significantly decreased (Fig. 6A) , and subsequent contraction elicited by Ca 2ϩ was markedly inhibited (Fig. 6B) . Similar results were obtained when U-46619 (100 nM) was used as a contractile agent. 6-AN (n ϭ 11) and Epi (n ϭ 6) depressed the force generated by U-46619 in the Ca 2ϩ -free condition (U-46619: 7.9 Ϯ 1.2 g vs. 6-AN: 3.1 Ϯ 1.1 g and Epi: 2.4 Ϯ 0.8 g) and after the addition of 1.5 mM Ca 2ϩ (U-46619: 14.9 Ϯ 1.5 g vs. 6-AN: 6.1 Ϯ 2.1 g and Epi: 2.4 Ϯ 0.8 g). There was a complete absence of BCA contraction to 30 mM KCl in Ca 2ϩ -free solution (data not shown). Subsequent addition of 1.5 mM Ca 2ϩ caused a sustained contraction in the absence of PPP inhibitors, and this sustained contraction was markedly inhibited by 6-AN and Epi (Fig. 6, C and  D) . Contraction elicited by the addition of Ca 2ϩ was eliminated by 6-AN (Fig. 6C) . The effects of Epi on the contraction-dependent contraction to Ca 2ϩ addition are shown in Fig. 6D . (Fig. 7, A and B) over the concentration ranges that caused BCA relaxation (Fig. 1, C and D) . Nifedipine (10 M) also decreased F 340 /F 380 by 60%. 5-HT elicited rapid peak increases in smooth muscle [Ca 2ϩ ] i , which were followed by a plateau phase (Fig. 7C) . In the presence of 6-AN or Epi, both phases of 5-HTinduced calcium signals were significantly diminished (Fig. 7, C and D) .
Effect of PPP inhibitors on changes in [Ca
Effect of TEA and DTT on the attenuation by PPP inhibitors of contractions to 5-HT and KCl in Ca
2ϩ -free solution and after Ca 2ϩ addition. To examine whether K ϩ channel and thiol redox mechanisms contribute to the inhibitory actions of 6-AN and Epi on contractile responses originating from the release of intracellular Ca 2ϩ and Ca 2ϩ influx, the effects of combinations of the thiol reductant DTT (3 mM) and the nonspecific K ϩ channel antagonist TEA (10 mM) on contractile responses of BCAs elicited by 10 M 5-HT (Fig. 8, A and  B) and 30 mM KCl (Fig. 8C) in Ca 2ϩ -free solution, followed by the addition of Ca 2ϩ , were studied in the absence or presence of 6-AN (5 mM). Blocking of K ϩ channels by TEA significantly (P Ͻ 0.005) increased the 5-HT-elicited contraction of BCAs in Ca 2ϩ -free solution, whereas this contraction was not altered by DTT (Fig. 8A) . However, pretreatment with TEA and/or DTT did not alter the inhibitory actions of 6-AN on this transient contraction initiated as a result of intracellular Ca 2ϩ release. Both DTT and TEA significantly increased the contraction of BCAs elicited by the addition of 1.5 mM Ca 2ϩ in the presence of 5-HT. In addition, DTT and/or TEA partly reversed the inhibition of contraction to Ca 2ϩ addition caused by 6-AN (Fig. 8B) . Similar studies were performed in the presence of 30 mM KCl (Fig. 8C ). TEA and DTT increased the force generated by Ca 2ϩ addition in the presence of 30 mM KCl in the absence of 6-AN (Fig. 8C) and partially reversed the inhibition of 30 mM KCl-elicited force by 6-AN. TEA and DTT did not have additive effects on force generation under the conditions examined.
DISCUSSION
The data in the present study suggest that increases in NADP ϩ -to-NADPH and GSSG-to-GSH ratios as shown in the model (Fig. 9 ) resulting from inhibition of 8; B ). An experiment (C) and summary data (D) show that 5-HT elicits rapid transient increases in arterial F340/ F380 that were followed by a plateau phase, which were both attenuated by the presence of 6-AN (1 mM, n ϭ 7) or Epi (100 M, n ϭ 6).
glucose-6-phosphate dehydrogenase, the rate-limiting enzyme in the PPP (20) , modulate force generation in endothelium-denuded BCA by activating relaxing mechanisms partially influenced by thiol redox. Decreases of [Ca 2ϩ ] i appear to be a major contributing process in the mechanisms of BCA relaxation resulting from inhibition of the PPP. However, the altered function of K v and K Ca channels also appear to modulate the observed relaxation.
In BCAs, it was observed that 6-AN (a competitive inhibitor of glucose-6-phosphate dehydrogenase) and Epi (a noncompetitive inhibitor of glucose-6-phosphate dehydrogenase) lowered NADPH and elevated NADP ϩ levels (Fig. 1) . These changes were associated with decreased GSH and increased GSSG, presumably due to a loss of redox control by systems including the NADPH-dependent GSH reductase reaction. The reduction of GSH levels (Fig. 2) theoretically could also result in an increase in H 2 O 2 levels; however, peroxide release appeared to be decreased in PPP-inhibited BCAs (Fig. 3) . While this could occur through either decreased generation or increased degradation of H 2 O 2 , PPP inhibition also caused a reduction in the detection of O 2 Ϫ (Fig. 3 ), the major source of H 2 O 2 generation in BCAs (15) . We speculate that due to elevation of GSSG and/or a loss of NADPH, the major source of O 2 Ϫ , NAD(P)H oxidase (15), may have been inhibited, resulting in lowered O 2 Ϫ and H 2 O 2 levels. Because two structurally different PPP inhibitors (6-AN and Epi) caused decreases in tissue NADPH levels and vasodilation, it seems likely that changes in NADP ϩ /NADPH levels and GSH redox were, at least in part, responsible for the vasodilation induced by the PPP inhibitors. Glycolysis and oxidative phosphorylation pathways do not seem to be involved in mediating smooth muscle relaxation induced by PPP inhibition, because in separate experiments, the glycolysis inhibitor 2-deoxyglucose and the mitochondrial electron transport inhibitors cyanide and antimycin did not have any effect on the force generated by 30 mM K ϩ . Consistent with this finding, it was also observed that the K ATP channel blocker glibebclamide did not have any blocking effect on the BCA relaxation elicited by 6-AN. The opening of K ϩ channels (K v and small-and large-conductance K ϩ channels) seems to modulate BCA relaxation resulting from PPP inhibition, because antagonists for these channels partially suppressed the 6-AN-elicited relaxation. In contrast, the K ϩ channel inhibitors did not alter relaxation in BCAs to the thiol oxidant diamide under the conditions examined in the present study (9) . Free radical generation and changes in the ratio of cellular reducing cofactors, including NAD ϩ /NADH, NADP ϩ /NADPH, and GSH/GSSG in VSM, and oxidizing agents have been proposed or reported to regulate the activity of K Ca , K ATP , and K v channels and to influence force generation through modulating membrane potential (22, 25) . K v channels are generally known to regulate resting membrane potential in coronary VSM (16) , and therefore changes in K v channel activity may be critical in modulating smooth muscle contractility. Oxidizing agents activate K ϩ currents, presumably by modifying a channel protein or by regulating the redox state of a cysteine residue that appears to regulate opening of the ion channel (11, 17, 18, 22, 25) . Oxidizing agents activate both K Ca and K v channels of isolated VSM cells from the rabbit pulmonary and ear artery (11, 17, 18) , and opening of K v channels partially contributes to the relaxation of the adult rat pulmonary artery and aorta induced by PPP inhibitors (5). Thus it seems that while the redox changes caused by PPP inhibition may have opened both K v and K Ca channels, their role was relatively minor and other mechanisms appear to be more important in eliciting relaxation of BCAs. The differences between previous reports (5, 11, 17, 18 ) and the present study may reflect the impact of species, age, vascular segments examined, baseline membrane potential, and/or experimental conditions on the redox-controlled systems being studied.
A potential mechanism responsible for the relaxation caused by PPP inhibition could be a lowering of intracellular Ca 2ϩ through inhibition of Ca 2ϩ release and influx mechanisms, by systems that are dependent and independent of control by K ϩ channels. PPP inhibitors did not cause relaxation in the presence of PDBu, an agent that causes a Ca 2ϩ -independent contraction of BCAs by activation of protein kinase C (9). Measurements with fura-2 ratios suggest that the initial 5-HTinduced transient elevation of [Ca 2ϩ ] i and the sustained increased levels of [Ca 2ϩ ] i , which are thought to increase the release of Ca 2ϩ from the sarcoplasmic reticulum followed by the influx of extracellular Ca 2ϩ through opening of receptor-operated channels (21), respectively, were both attenuated by PPP inhibition. -free Krebs solution containing 5-HT or KCl, and it attenuated the nearcomplete inhibition of these responses by 6-AN. These findings suggest that thiol-reducing conditions enhance the entry of extracellular Ca 2ϩ through receptorand voltage-regulated channels and that a thiol redox site regulated by PPP inhibition appears to control Ca 2ϩ influx through these channels. These thiol redoxassociated actions of PPP inhibition are similar to the previously reported actions of the thiol oxidant diamide in BCAs (9) . The absence of effects of DTT and TEA on the transient contraction to 5-HT under Ca 2ϩ -free conditions is consistent with the idea that PPP inhibition also activates relaxation through processes that control [Ca 2ϩ ] i release and/or force generation by Ca 2ϩ through mechanisms that are not influenced by thiol redox and the function of K ϩ channels under the conditions examined. Thiol oxidation-regulated processes appear to inhibit L-type Ca 2ϩ channels and nonselective cation channel transmembrane Ca 2ϩ influx in VSM and cardiac myocytes (2, 10) , and L-type Ca 2ϩ inhibition by Epi is associated with inhibition of myocardial contractility (8) . Although opening of K ϩ channels seems to be a contributing mechanism to BCA relaxation elicited by PPP inhibitors, mechanisms controlling Ca 2ϩ release and influx appear to be the primary processes that mediate relaxation induced by 6-AN and Epi.
It seems logical to assume that signaling mechanisms mediated through cAMP and cGMP (16, 28) could contribute to the vasoactive actions of PPP inhibitors. However, the guanylate and adenylate cyclase inhibitors LY83583 and DDA, respectively, did not significantly affect the relaxation induced by PPP inhibition (Fig. 3) . These observations are consistent with previous studies reporting that Epi and 6-AN open K ϩ channels of VSM and/or cause relaxation in the rat pulmonary artery and aorta, rabbit coronary artery, and isolated ferret and rat lungs in an endothelium-, receptor-, cAMP-, cGMP-, prostaglandin-, and NO-independent manner (3, 5, 29) . Because PPP inhibition suppressed H 2 O 2 generation, and neither the cell-permeable H 2 O 2 scavenger ebselen nor hypoxia affected the BCA relaxation induced by 6-AN, it is unlikely that peroxide has a role in relaxation caused by PPP inhibition. Nonetheless, the thiol reductant DTT partly suppressed the 6-AN-and Epi-induced BCA relaxation and facilitated force generation by Ca 2ϩ addition to Ca 2ϩ -free conditions. Therefore, it can be suggested that signaling processes controlled by increases in GSSG and/or S-thiolation, and processes directly controlled by NADP(H) redox, regulate channel activity and ionic homeostasis. For example, there is evidence for NADPH-controlled oxidoreductases on the ␤-subunit of K v channels (13, 19) and the skeletal muscle ryanodine-sensitive Ca 2ϩ release channel (1), which could potentially regulate relaxation through a direct action of cytosolic NADPH redox on these ion channels.
This study provides evidence for the novel concept of an important role for the PPP, a key redox regulating pathway, and a loss of cytosolic NADPH in controlling the relaxation of BCAs through the coordination of processes including potentially minor roles for the opening of K v and K Ca channels and major roles for processes that control the inhibition of Ca 2ϩ release and influx. Because the mechanisms are activated by lowering of NADPH levels, they may compensate for the potential loss of cGMP-dependent relaxation due to an impairment of NO biosynthesis and reduction of the sGC heme to the Fe 2ϩ form required for NO activation, which are NADPH-dependent processes (7, 12) . A deficiency of glucose-6-phosphate dehydrogenase activity in the African-American population is associated with endothelial oxidant stress, decreased NO bioavailability, and an increased risk for vascular disease in the absence of hypertension (4, 12) . In addition, inhibition of the PPP almost completely abolishes acute hypoxic pulmonary vasoconstriction in isolate rat lungs (5) . The activity of the PPP and the redox status of cytosolic NADP(H) are fundamental cellular metabolic systems that could be influenced by many physiological processes that regulate vascular function. Thus the PPP and cytosolic NADP(H) redox may be important additional systems that control vascular function in response to physiological, pathophysiological, metabolic, and oxidative stress conditions. 
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